Parker Waichman LLP Headlines by Topic
Epilepsy Drugs
Study Finds Some New Epilepsy Treatments May Up Suicide Risks
Jul 27, 2010
| Parker Waichman LLP
A recent study has found evidence that the newer epilepsy drugs Keppra, Topamax, and Sabril are associated with a higher risk of suicidal behavior...
Epilepsy Drugs Linked to Birth Defects
Dec 7, 2009
| Parker Waichman LLP
A new study of antiepileptic drugs (AEDs) has found that pregnant women taking such medications were more likely to give birth to children with...
Valproate Raises Risk of Neural Tube Defects, Other Birth Defects, FDA Says
Dec 3, 2009
| Parker Waichman LLP
Valproate has been associated with a higher risk of neural tube defects and other major birth defects, such as craniofacial defects and...
Another Valproate Study Sees Problems for Developing Fetus
Jul 22, 2009
| Parker Waichman LLP
Children exposed to valproate in-utero may exhibit lower IQs as toddlers than children whose mothers took other epilepsy drugs, according to...
Suicide Warnings Approved for Epilepsy Drugs
May 6, 2009
| Parker Waichman LLP
Federal regulators have approved new suicide warnings for more than two dozen epilepsy drugs. The Food & Drug Administration (FDA) had...
Valproate Shouldn't be Taken by Pregnant Women, Medical Groups Say
Apr 28, 2009
| Parker Waichman LLP
The epilepsy drug valproate (Depacon) should not be taken by pregnant women, according to new guidelines issued by American Academy of Neurology and...
Valproate During Pregnancy Linked to Children with Lower IQs
Apr 16, 2009
| Parker Waichman LLP
Valproate (sold under the brand names Depacon and Depakene) taken during pregnancy may cause children to have lower IQs, according to a new study...
Zonegran Linked to Blood Disorder
Feb 23, 2009
| Parker Waichman LLP
The epilepsy drug zonisamide, sold both generically and under the brand name Zonegran, can cause a serious blood disorder called metabolic acidosis,...
Valproate Use During Pregnancy Linked to Autism
Dec 2, 2008
| Parker Waichman LLP
Mothers who take the epilepsy drug valproate (sold under the brand names Depacon and Depakene) during pregnancy may face an increased risk of having...
Advisory Panel Rejects 'Black Box' Warnings of Suicide Risk on Epilepsy Drugs
Jul 11, 2008
| Parker Waichman LLP
An expert advisory panel refused a Food & Drug Administration (FDA) proposal to place a “Black Box”—the agency’s...
